Foscarnet: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Antiviral *Dosage Forms: *Routes of Administration: IV *Common Trade Names: Foscavir ==Adult Dosing== *CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg I...") |
(Restore original dosing content alongside dynamic SMW tables) |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: Antiviral | *Type: [[Antiviral]] | ||
*Dosage Forms: | *Dosage Forms: | ||
*Routes of Administration: IV | *Routes of Administration: IV | ||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily | *CMV retinitis: 90 mg/kg IV q12h '''OR''' 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily | ||
*HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily | *HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily | ||
*VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h | *VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h | ||
===Indications by Disease=== | |||
{{#ask: [[Has DrugName::Foscarnet]] [[Has Population::Adult]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Indications by Disease=== | |||
{{#ask: [[Has DrugName::Foscarnet]] [[Has Population::Pediatric]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Special Populations== | ==Special Populations== | ||
| Line 50: | Line 76: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:ID]] | |||
Latest revision as of 02:38, 20 March 2026
Administration
- Type: Antiviral
- Dosage Forms:
- Routes of Administration: IV
- Common Trade Names: Foscavir
Adult Dosing
- CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily
- HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily
- VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| CMV colitis | 90mg/kg IV q12hrs x 21 days | Until symptom resolution |
| CMV neurologic disease | 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs | Combined with Ganciclovir |
| Encephalitis | 90mg/kg IV every 12 hrs | CMV |
Pediatric Dosing
Indications by Disease
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: Complicated dose adjustment required!
- Hepatic dosing: No adjustement
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hyperphosphatemia, hypophosphatemia, hypocalcemia, hypokalemia, hypomagnesemia
- Pancreatitis
- Pancytopenia
- Renal failure, renal impairment
- Seizure
Common
- Nausea, vomiting, diarrhea
- Anemia, granulocytopenic disorder
- Headache
- Fever
Pharmacology
- Half-life: 3.3-4h
- Metabolism:
- Excretion: Renal
Mechanism of Action
- inhibits pyrophosphate binding on viral DNA polymerases